Brief: Genfit SA -Genfit Is Eligible To Receive A EUR 48.7 Million Milestone Payment From Ipsen Upon First Commercial Sale Of Iqirvo In U.S.
10/06/2024 22:25
Genfit SA GNFT.PA :
* GENFIT SA -GENFIT IS ELIGIBLE TO RECEIVE A EUR 48.7
MILLION
MILESTONE PAYMENT FROM IPSEN UPON FIRST COMMERCIAL SALE OF
IQIRVO IN U.S.
Source text for Eikon: ID:nGNX3KqL5H
Further company coverage: GNFT.PA
Recent news on Genfit SA
See all newsFrance's Genfit H1 revenue falls due to absence of milestone payments
French and Benelux stocks-Factors to watch on September 15
Brief: Genfit SA - Advances Nangibotide In Phase 2 Clinical Investigation In Aclf
Brief: Euronext Includes Genfit, Inventiva In SBF120 Index; Interparfums, Verallia Excluded
Brief: Genfit March 31 Cash And Cash Equivalents EUR 136.1 Million